)
Alkermes (ALKS) investor relations material
Alkermes TD Cowen 46th Annual Health Care Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business transformation and strategic positioning
Completed a significant transition in 2025, consolidating focus around sleep medicine and expanding with the acquisition of Avadel.
Now positioned as a major player in the sleep medicine market, leveraging a strong, cash-generative base business to fund pipeline growth.
Acquisition of Avadel adds oxybate to the portfolio, supporting both current market presence and the upcoming launch of alixorexton.
Integration of Avadel's experienced commercial team is expected to enhance future product launches.
Commercial infrastructure is now scalable and profitable, supporting aggressive pipeline investment.
Sleep medicine and narcolepsy market insights
Oxybates remain a key treatment for narcolepsy, especially as diagnosis and treatment rates increase.
The company is uniquely positioned to research and develop combined daytime and nighttime therapies for narcolepsy.
There is a large gap between narcolepsy prevalence and treatment, with significant unmet patient needs.
The launch of alixorexton is expected to benefit from established commercial relationships in specialized sleep centers.
Orexin agonist development and clinical program
Phase II data for orexin 2 receptor agonists show strong safety, tolerability, and efficacy, with once-daily and split dosing options.
Phase III program includes three studies (two NT1, one NT2), with endpoints such as Maintenance of Wakefulness Test (MWT) and Epworth Sleepiness Scale (ESS).
Split dosing is being incorporated to extend wakefulness for patients who need it.
Methodological improvements in cataplexy monitoring and site quality are being applied in phase III.
Data for idiopathic hypersomnia (IH) are expected soon, with both LUMRYZ and orexin compounds being evaluated.
Next Alkermes earnings date
Next Alkermes earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)